Official Statistics

Cancer services profiles: short statistical commentary, December 2020

Published 1 December 2020

Applies to England

New in this update

All indicators have been updated with the 2019 to 2020 financial year of data, except for the crude cancer incidence rate which has been updated with data from 2018 to 2019.

Main findings

The latest updates show that in 2019 to 2020:

  • 70.1% and 72.3 % of females attended breast cancer and cervical screening within the target period respectively. For bowel cancer screening, 63.8% of 60 to 74 years olds attended in the last 30 months
  • for diagnostic investigations per 100,000 population, there were 798 colonoscopy procedures, 1,233 upper gastro-intestinal (GI) endoscopy procedures and 559 sigmoidoscopy procedures performed
  • there were 3,896 two-week wait (TWW) referrals per 100,000 population. The proportion of new cancer cases treated that were referred by TWW (detection rate) was 53.7%
  • the number of new malignant cancer cases was updated for 2018 to 2019, reporting 317,384 new cases respectively (excluding non-melanoma skin cancer). The incidence for 2018 to 2019 was 529 cases per 100,000 population
  • the rate of individuals diagnosed with cancer through an emergency route was 85 per 100,000 population

Background

28 indicators in the Cancer Services profile have been updated to include the latest financial year of data that are available (2019 to 2020), collated by the National Cancer Registration and Analysis Service. The cancer incidence indicator has been updated to include the 2018 to 2019 data.

The profiles are for commissioners and health professionals to use when assessing the impact of cancer in their local population and making decisions about services. The indicators provide information on demographics; cancer screening; TWW referrals; diagnostic services; emergency presentations and admissions by general practitioner (GP) practice, Primary Care Network, Clinical Commissioning Group and at National level.

Data are shown for the 6,699 GP practices which have a list size of ≥1000 patients and were either listed in the Quality and Outcomes Framework (QOF) 2019 to 2020 or were listed in both the Attribution Data Set (ADS) and GP patient survey (GPPS) datasets.

Further Information

Please follow the links for more details on the following:

Cancer Services profile

Public Health England’s 5-year approach to cancer from 2017 to 2021

Cancer Research UK’s Facilitator Programme

Responsible lead: Jack Anderson

For queries relating to this publication, please contact jack.anderson@phe.gov.uk